COMMUNITY HEALTH SYSTEMS INC (CYH) stock intrinsic value fair value estimate & owner earnings analysis

Community Health Systems operates 69 general acute-care hospitals across 14 states, mostly in mid-sized and rural communities where it is often the only hospital in the market. Over the past decade the company has shrunk deliberately, selling off dozens of hospitals to pay down debt; total debt has fallen from roughly $15 billion in 2016 to about $10.4 billion at the end of 2025, funded in part by a large divestiture that alone raised over $1.2 billion in 2025. That debt load is the central fact of this business. Revenue has been broadly stable for the past four years, in the $12.2-12.6 billion range, but with $10+ billion of debt sitting ahead of shareholders, only a thin sliver of the cash the hospitals generate is left over for common stockholders after interest, reinvestment in the hospitals, and the share that belongs to physician and health-system partners who co-own a number of the hospitals as joint ventures. On our normalized measure of owner earnings - operating cash flow after removing working-capital swings, stock compensation, the cash needed just to maintain (not grow) the hospital base, and the joint-venture partners' share - the last four fiscal years have run close to breakeven per share: a strong 2022, two negative years in 2023 and 2024, and a modest positive result in 2025. We treated 2020 and 2021 as distorted by one-time pandemic-era federal payment programs (an emergency Medicare advance received in 2020 and repaid in 2021) rather than using them to set the normal level of earnings. A specific, disclosed fact worth calling out: interest expense has risen for two straight years (to $870 million in 2025) even as the company has paid down principal, because older, cheaper debt is rolling into higher-rate debt. That undercuts the simple story that debt paydown alone will quickly free up more cash for shareholders, and we have not assumed it will. Looking forward, the company itself has flagged a concrete risk: enhanced Affordable Care Act insurance subsidies expired at the end of 2025, and management expects this, along with related 2025 federal law changes, to reduce the number of privately insured patients coming through its doors. Because the equity here already runs so thin, even a modest hit to insured volume could push owner earnings back to roughly breakeven or negative, as happened in 2023 and 2024. Because of the heavy leverage, the value of the shares is unusually sensitive to small changes in the hospitals' underlying cash flow - much more sensitive than the hospitals' operations themselves. In our bear case, the loss of ACA subsidies bites as management has flagged, interest costs stay elevated, and owner earnings stay near zero to modestly negative for several years; on that path the shares are worth under $1. In our base case, the hospital base keeps producing roughly steady, modestly growing cash flow, and debt reduction continues at a measured pace; we estimate the shares are worth a bit over $2. In our bull case, the company keeps executing the debt-reduction playbook it has already demonstrated (repeated hospital sales funding debt paydown) and rising interest costs level off, letting more of the cash flow through to shareholders; on that path we estimate the shares could be worth over $12. That is an unusually wide range, and it is a direct consequence of how much debt sits ahead of the equity - it is not a sign of a badly built estimate. Given that width, the margin-of-safety price sits at a large discount to our base-case estimate, and assumes at least one full year of results confirming that the loss of ACA subsidies did not push cash generation back into negative territory.